Written by Jacob Andrews.

A recently leaked video has surfaced, showing Moderna CEO Stéphane Bancel in a shocking conversation with former NAID Director Anthony Fauci. In this footage, Bancel suggests faking a pandemic just a month before COVID-19 emerged. This revelation has sparked intense scrutiny and concern about the origins and handling of the COVID-19 pandemic.

In the 2021 interview with Atlas Venture, Bancel admits discussing pandemic readiness with Fauci. “At the end of the day, we talked to Tony about something I’ve always been passionate about, which is outbreak and pandemic readiness because I knew the mRNA technology could go so fast,” Bancel can be heard saying. His words suggest a premeditated approach to pandemic scenarios, raising questions about the transparency and ethics of their conversation.

Bancel continues, proposing a mock outbreak: “I say one day we should mock up an outbreak where you guys send us by email a sequence of a virus you pick, and we start the clock watch and see how quickly we can give you GNP dose to get into the clinic.” He boasts about the speed at which they could produce a GNP product, claiming less than 60 days, despite laughter and skepticism from others.

Moderna’s Preparation and Davos Insights

Bancel’s remarks didn’t stop at hypothetical scenarios. He also shared insights from his visit to the World Economic Forum’s annual Davos Summit in 2020. According to Bancel, this event left him convinced that a pandemic was imminent. This belief seemingly influenced Moderna’s actions and preparations leading up to the global COVID-19 outbreak.

Adding to the controversy, Bancel revealed details about Moderna’s corporate culture. He admitted that the company paused vaccine trials due to a lack of diversity, stating there were “too many white people in the study.” This decision has sparked debate over the balance between scientific rigor and social considerations in medical research.

Further complicating the narrative, in 2022, Bancel struggled to explain why COVID-19 was found to contain a gene sequence patented by Moderna three years before the pandemic. This revelation challenges the dominant narrative that SARS-CoV-2 emerged naturally from a wet market in Wuhan, China.

The Fallout and Public Reaction

The implications of Bancel’s conversation with Fauci are far-reaching. The idea of mocking up an outbreak, combined with the rapid development timeline for a GNP product, raises ethical and scientific concerns. Was the world’s response to COVID-19 influenced by pre-existing plans and preparations that the public was unaware of?

Bancel’s comments at the Davos Summit also suggest that key industry leaders anticipated a pandemic, yet this foresight did not translate into transparent, proactive measures to mitigate the crisis. Instead, it appears there was a focus on showcasing the capabilities of mRNA technology and preparing for potential outbreaks in a controlled manner.

The controversy over Moderna’s vaccine trials being paused for diversity reasons highlights the tension between ensuring equitable representation in research and maintaining the highest standards of scientific practice. Critics argue that halting trials based on racial composition could undermine the reliability and validity of the results.

Our Take

The leaked video of Stéphane Bancel and Anthony Fauci’s conversation raises serious questions about the handling and origins of the COVID-19 pandemic. From a politically conservative perspective, this situation underscores the dangers of unchecked power and lack of transparency in public health decisions. The idea of faking a pandemic, even hypothetically, reveals a troubling willingness to manipulate scenarios for testing technologies.

Bancel’s revelations about Moderna’s internal decisions and the pre-pandemic insights from the Davos Summit suggest that key players in the health and biotech industries had significant foresight. Yet, this foresight was not accompanied by a commitment to open communication with the public. Instead, it appears there was an effort to control the narrative and outcomes behind closed doors.

Moreover, the controversy over pausing vaccine trials for diversity reasons points to a broader issue of political correctness potentially interfering with scientific integrity. While diversity in research is important, it should not come at the expense of rigorous scientific standards. The primary goal must always be the development of safe and effective medical treatments based on sound science.

Ultimately, this situation highlights the need for greater accountability and transparency in public health and medical research. The public deserves to know the full context and motivations behind critical decisions that affect global health. Trust in our institutions depends on their commitment to honesty, ethical conduct, and putting the public’s welfare above all else.